U.S. Markets open in 8 hrs 25 mins

Aptorum Group Limited (APM)

NasdaqGM - NasdaqGM Real Time Price. Currency in USD
Add to watchlist
2.2500-0.0500 (-2.17%)
At close: 4:00PM EDT
Full screen
Trade prices are not sourced from all markets
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Neutralpattern detected
Previous Close2.3000
Open2.2600
Bid0.0000 x 2200
Ask0.0000 x 1100
Day's Range2.1500 - 2.2900
52 Week Range1.1600 - 18.2500
Volume455,006
Avg. Volume1,627,148
Market Cap76.527M
Beta (5Y Monthly)N/A
PE Ratio (TTM)N/A
EPS (TTM)-0.5360
Earnings DateApr 29, 2020
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target Est13.00
  • Aptorum Group Limited to Hold Annual General Meeting of Shareholders on December 9, 2020
    Business Wire

    Aptorum Group Limited to Hold Annual General Meeting of Shareholders on December 9, 2020

    Regulatory News: Aptorum Group Limited (Nasdaq: APM; Euronext Paris: APM) (the "Company", "Aptorum Group" or "Aptorum"), a biopharmaceutical company focused on novel technologies including the targeting of infectious diseases, today announced it will hold its 2020 annual general meeting of shareholders at its Hong Kong office located at 17/F, Guangdong Investment Tower, 148 Connaught Road Central, Hong Kong at 8:00 p.m. Hong Kong Time on December 9, 2020 (7:00 a.m. Eastern Standard Time on December 9, 2020 / 12:00 p.m. Greenwich Mean Time on December 9, 2020 / 1:00 p.m. Central European Time on December 9, 2020).

  • Aptorum Group Announces Closing of $9.0 Million Public Offering
    Business Wire

    Aptorum Group Announces Closing of $9.0 Million Public Offering

    Aptorum Group Limited (Nasdaq:APM, Euronext Paris:APM) ("Aptorum Group" or "Aptorum"), a biopharmaceutical company focused on novel technologies including the targeting of infectious diseases, today announced the closing of a public offering of 2,769,231 Aptorum’s Class A ordinary shares (or ordinary share equivalents) and warrants to purchase up to 2,769,231 Class A Ordinary Shares, at a combined public offering price of $3.25 per share and related warrant. The warrants have an exercise price of $3.25 per share, are exercisable immediately upon issuance and expire on the five year anniversary of the date of issuance.

  • Aptorum Group Announces Pricing of $9.0 Million Public Offering
    Business Wire

    Aptorum Group Announces Pricing of $9.0 Million Public Offering

    Regulatory News: Aptorum Group Limited (Nasdaq:APM, Euronext Paris:APM) ("Aptorum Group" or "Aptorum"), a biopharmaceutical company focused on novel technologies including the targeting of infectious diseases, today announced the pricing of a public offering of 2,769,231 Aptorum’s Class A ordinary shares (or ordinary share equivalents) and warrants to purchase up to 2,769,231 Class A Ordinary Shares, at a combined public offering price of $3.25 per share and related warrant. The warrants have an exercise price of $3.25 per share are exercisable immediately upon issuance and expire on the five year anniversary of the date of issuance.